{"id":9508,"date":"2026-04-29T09:19:38","date_gmt":"2026-04-29T16:19:38","guid":{"rendered":"https:\/\/pandapeptides.com\/research\/5-amino-1mq\/"},"modified":"2026-04-29T09:20:19","modified_gmt":"2026-04-29T16:20:19","slug":"5-amino-1mq","status":"publish","type":"page","link":"https:\/\/pandapeptides.com\/es\/research\/5-amino-1mq\/","title":{"rendered":"5-Amino-1MQ \u2014 Published Research"},"content":{"rendered":"<div style=\"max-width:800px;margin:0 auto\">\n<p style=\"color:#a1a1aa;font-size:14px;margin-bottom:30px\"><a href=\"\/es\/producto\/5-amino-1mq\/\" style=\"color:#00e5ff\">\u2190 Back to 5-Amino-1MQ product page<\/a><\/p>\n<section style=\"background:#111827;border-radius:14px;padding:20px 22px;margin:28px 0\">\n<h2 style=\"color:#fafafa;margin:0 0 10px;font-size:24px\">How to read this 5-Amino-1MQ research page<\/h2>\n<p style=\"color:#a1a1aa;line-height:1.7;margin:0 0 12px\">This page summarizes 5-Amino-1MQ literature around NNMT inhibition, NAD+-pathway context, and experimental metabolic-marker models. It is a literature map and documentation companion, not a protocol or human-use resource.<\/p>\n<ul style=\"color:#a1a1aa;line-height:1.7;margin:0 0 12px 20px\">\n<li><strong style=\"color:#fafafa\">Compound identity:<\/strong> 5-Amino-1MQ is discussed here as a small-molecule NNMT inhibitor research compound; CAS 42464-85-9.<\/li>\n<li><strong style=\"color:#fafafa\">Research framing:<\/strong> citations are grouped by experimental theme and should not be interpreted as product claims or intended uses.<\/li>\n<li><strong style=\"color:#fafafa\">Documentation links:<\/strong> compare the <a href=\"\/es\/producto\/5-amino-1mq\/\" style=\"color:#00e5ff\">catalog listing<\/a>, <a href=\"\/es\/coa\/\" style=\"color:#00e5ff\">COA hub<\/a>, y <a href=\"\/es\/research-framework\/\" style=\"color:#00e5ff\">research framework<\/a>.<\/li>\n<\/ul>\n<p style=\"color:#71717a;font-size:13px;line-height:1.6;margin:0\">Panda Peptides products are for research use only. No dosing, administration, treatment, outcome, metabolic-benefit, or human-use guidance is provided.<\/p>\n<\/section>\n<div style=\"margin-top:40px;max-width:900px\">\n<h3 style=\"color:#fafafa;font-size:22px;margin-bottom:8px\">Biblioteca de investigaci\u00f3n<\/h3>\n<p style=\"color:#71717a;font-size:13px;margin-bottom:20px\">Published research references for 5-Amino-1MQ \u2014 research reference only, not medical guidance<\/p>\n<details style=\"background:#18181b;border-radius:10px;margin-bottom:12px;overflow:hidden\">\n<summary style=\"padding:18px 24px;color:#00e5ff;font-size:16px;font-weight:600;cursor:pointer\">5-Amino-1MQ and NNMT Inhibition Models<\/summary>\n<div style=\"padding:0 24px 20px;color:#a1a1aa;font-size:15px;line-height:1.7\">\n<p>5-Amino-1MQ has been studied as a nicotinamide N-methyltransferase (NNMT) inhibitor in adipocyte and metabolic-model research. Published work uses the compound to examine NNMT activity, NAD+ salvage-pathway markers, and cellular energy-metabolism endpoints in experimental systems.<\/p>\n<p style=\"font-size:12px;color:#52525b;font-style:italic\">Source: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5826726\/\" style=\"color:#71717a\" rel=\"nofollow noopener\" target=\"_blank\">PMC5826726<\/a><\/p>\n<\/div>\n<\/details>\n<details style=\"background:#18181b;border-radius:10px;margin-bottom:12px;overflow:hidden\">\n<summary style=\"padding:18px 24px;color:#00e5ff;font-size:16px;font-weight:600;cursor:pointer\">NNMT Pathway Literature Context<\/summary>\n<div style=\"padding:0 24px 20px;color:#a1a1aa;font-size:15px;line-height:1.7\">\n<p>NNMT literature provides pathway context for interpreting 5-Amino-1MQ studies, including nicotinamide methylation, methyl-donor metabolism, and cellular NAD+-related measurements. These references are useful for research orientation and assay-design background only.<\/p>\n<p style=\"font-size:12px;color:#52525b;font-style:italic\">Source: <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8337113\/\" style=\"color:#71717a\" rel=\"nofollow noopener\" target=\"_blank\">PMC8337113<\/a><\/p>\n<\/div>\n<\/details>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>\u2190 Back to 5-Amino-1MQ product page How to read this 5-Amino-1MQ research page This page summarizes 5-Amino-1MQ literature around NNMT inhibition, NAD+-pathway context, and experimental metabolic-marker models. It is a literature map and documentation companion, not a protocol or human-use resource. Compound identity: 5-Amino-1MQ is discussed here as a small-molecule NNMT inhibitor research compound; CAS [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":7787,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-9508","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/9508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/comments?post=9508"}],"version-history":[{"count":1,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/9508\/revisions"}],"predecessor-version":[{"id":9511,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/9508\/revisions\/9511"}],"up":[{"embeddable":true,"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/pages\/7787"}],"wp:attachment":[{"href":"https:\/\/pandapeptides.com\/es\/wp-json\/wp\/v2\/media?parent=9508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}